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Abstract
Background: Enzymatically modified isoquercitrin (EMIQ) is produced from rutin using enzymatic hydrolysis
followed by treatment with glycosyltransferase in the presence of dextrin to add glucose residues. EMIQ is
absorbed in the same way as quercetin, a powerful antioxidant reported to prevent disused muscle atrophy by
targeting mitochondria and to have ergogenic effects. The present study investigated the effect of EMIQ on skeletal
muscle hypertrophy induced by functional overload.
Methods: In Study 1, 6-week-old ICR male mice were divided into 4 groups: sham-operated control, sham-operated
EMIQ, overload-operated control, and overload-operated EMIQ groups. In Study 2, mice were divided into 3 groups:
overload-operated whey control, overload-operated whey/EMIQ (low dose), and overload-operated whey/EMIQ
(high dose) groups. The functional overload of the plantaris muscle was induced by ablation of the synergist
(gastrocnemius and soleus) muscles. EMIQ and whey protein were administered with food. Three weeks after the
operation, the cross-sectional area and minimal fiber diameter of the plantaris muscle fibers were measured.
Results: In Study 1, functional overload increased the cross-sectional area and minimal fiber diameter of the
plantaris muscle. EMIQ supplementation significantly increased the cross-sectional area and minimal fiber diameter
of the plantaris muscle in both the sham-operated and overload-operated groups. In Study 2, EMIQ
supplementation combined with whey protein administration significantly increased the cross-sectional area and
minimal fiber diameter of the plantaris muscle.
Conclusion: EMIQ, even when administered as an addition to whey protein supplementation, significantly
intensified the fiber hypertrophy of the plantaris muscle in functionally overloaded mice. EMIQ supplementation
also induced fiber hypertrophy of the plantaris in sham-operated mice.
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protein
* Correspondence: takemasa.tohru.gm@u.tsukuba.ac.jp
2Health and Sport Sciences, Graduate School of Comprehensive Human
Sciences, University of Tsukuba, Tsukuba, Japan
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kohara et al. Journal of the International Society of Sports Nutrition  (2017) 14:32 
DOI 10.1186/s12970-017-0190-y
Background
Rutin is a flavonoid glycoside that is ubiquitously present
in a variety of fruits and vegetables, such as onions and
buckwheat. Rutin is converted into quercetin and its me-
tabolites before absorption [1]. Rutin and quercetin are
known as vitamin P and play various roles in cardiovas-
cular and metabolic disease [2]. As for the role of rutin
in muscle, Mukai et al. reported that quercetin injection
suppressed muscle atrophy by attenuating the induction
of ubiquitin ligases [3]. They also found that quercetin
intake prevented muscle atrophy by targeting mitochon-
drial function [4]. According to Seo et al., rutin intake
increased the size of mitochondria and mitochondrial
DNA content, as well as stimulated mitochondrial bio-
genesis [5]. Therefore, rutin and quercetin have a benefi-
cial effect in muscle atrophy. It has also been reported
that quercetin supplementation has an ergogenic effect
[6]. However, the effects of rutin and its metabolites in
muscle hypertrophy have remained unknown.
Rutin and quercetin are poorly absorbed when admin-
istered orally, which diminishes their positive health ef-
fects [1]. Therefore, several trials have been conducted
to increase the bioavailability of these compounds. Since
quercetin is nearly insoluble in water (<0.1 g/100 mL at
21 °C), enzymatic glucosyl conjugation has been per-
formed to enhance its water solubility [7, 8]. Enzymati-
cally modified isoquercitrin (EMIQ) (Fig. 1) is one of
water soluble glucoside derivatives of quercetin. EMIQ
is produced from rutin via enzymatic hydrolysis, which
removes the rhamnosyl group, followed by treatment of
the product with glycosyltransferase in the presence of
dextrin to add glucose residues. The bioavailability of
EMIQ, which is absorbed as quercetin and metabolized
like rutin, is about 17-fold greater than that of quer-
cetin [8]. It is therefore reasonable to expect consid-
erably greater health benefits with EMIQ. In Japan,
EMIQ is approved as a food additive [9], and the U.S.
FDA concluded that EMIQ is generally regarded as
safe (GRAS) for use as an antioxidant. The level of
EMIQ in a food product is recommended to be no
greater than 150 mg/kg, with the exception of chew-
ing gum, in which the antioxidant may be present up
to 1500 mg/kg [10].
Skeletal muscle mass is maintained by a balance be-
tween synthesis and breakdown, with disproportionally
increased protein synthesis leading to muscle fiber
hypertrophy. Resistance training is known to induce
muscle fiber hypertrophy, which is important to enhance
exercise capacity and locomotive power in athletes and
the elderly [11]. Protein and especially essential amino
acids supplementation augments the muscle hypertrophy
during resistance training [12, 13]. During resistance
training, many athletes consume whey protein, which is
known to augment muscle hypertrophy.
In this study, we used a mouse model of functional
overload created by synergist ablation surgery. Surgical
removal of the gastrocnemius and soleus muscles re-
sulted in functional overload of the remaining plantaris
muscle, leading to myofiber hypertrophy mimicking the
effect of resistance training [14]. The purpose of this
study was to evaluate the effect of EMIQ supplementa-
tion on muscle hypertrophy in these functionally over-
loaded mice. The effect of EMIQ supplementation
simultaneously with whey protein was also evaluated.
Methods
Animals and experimental design
Male ICR mice (6 weeks old, n = 59) were obtained from
Clea Japan Inc. Animals were maintained under standard
conditions (temperature: 23 ± 2 °C, humidity: 50 ± 10%,
12:12-h light-dark cycle; lights on at 7:00 a.m.) with ad
libitum access to food (Study 1: CE2, Clea Japan Inc.;
Study 2: CE2 and AIN-93G, Oriental Yeast Co.) and
water. After a 14-day acclimatization to the laboratory
conditions, ablation of the synergistic gastrocnemius and
soleus muscles was performed, and mice were main-
tained on standard bedding for one week. Thereafter,
mice were individually housed on wire floor. They lived
as they did in the cage previously. The body weight and
food intake in each group were measured thrice a week.
All animal experiments were carried out in a humane
manner after receiving approval from the Institutional
Animal Experiment Committee of the University of Tsu-
kuba (identification number: 09–058) and in accordance
with the Regulations for Animal Experimentation of the
University and Fundamental Guidelines for Proper Con-
duct of Animal Experiments and Related Activities in
Academic Research Institutions under the jurisdiction of
Ministry of Education, Culture, Sports, Science and
Technology of Japan.
Surgical procedure
In order to initiate overload-induced hypertrophy of the
plantaris muscle, ablation of the synergistic gastrocne-
mius and soleus muscles was performed as described
previously [15, 16]. Briefly, under pentobarbital sodium
anesthesia (0.5%; 10 μL/g body weight), a skin incision
was made from the popliteal to the Achilles tendon. The
soleus muscle was completely removed except for a
small portion at the proximal end, where it attaches to
the plantaris. Both the lateral and medial gastrocnemius
muscles were also completely removed. Care was taken
to avoid trauma to the plantaris. In control groups, a
sham operation was performed by making the skin inci-
sion only. The animals were sacrificed 3 weeks after the
surgery, and the plantaris muscles of both hind limbs
were excised and measured for weight. The samples
were embedded in tissue-freezing medium (OCT
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compound, Sakura Finetek Japan), flash-frozen in liquid
nitrogen, and stored at −80°C until use.
EMIQ supplementation
EMIQ was obtained from Sanei-gen FFI Inc. The dosage
of EMIQ supplementation was determined according to
the previous study [17]. EMIQ was administered with
diet at an average dose of approximately 4.0 mg/kg of
body weight in study 1, and approximately 4.0 and
40 mg/kg of body weight in +EMIQ (L) and +EMIQ (H)
groups, respectively, in study 2.
Study 1. The mice were randomly divided into four
groups: sham-operated control (“Sham,” n = 9), sham-
operated EMIQ (“Sham + EMIQ,” n = 9), overload-
operated control (“Overload,” n = 10), and overload-
operated EMIQ (“Overload + EMIQ,” n = 9). The con-
trol mice were kept on a normal diet (CE-2, Clea Japan
Inc.), whereas mice in the EMIQ groups received the
same diet and EMIQ (0.003%, Clea Japan Inc.) for
3 weeks (Table 1).
Study 2. The mice were randomly divided into three
groups: overload-operated control mice that received
whey protein supplementation (“Overload + W,” n = 7),
overload-operated mice that received whey protein and
a low dose of EMIQ (“+EMIQ (L),” n = 7), and
overload-operated mice that received whey protein and
a high dose of EMIQ (“+EMIQ (H),” n = 8). The mice in
the whey control group received a diet in which milk ca-
sein in AIN-93G was replaced with whey protein (Clea
Japan Inc.), whereas the mice in the whey EMIQ groups
were fed the same whey diet and EMIQ (low dose:
0.003%; high dose: 0.03%) for 3 weeks (Table 2).
Immunohistochemical analysis
For immunohistochemical analysis, serial cross-sections
(10-μm thick) of plantaris muscles were cut and stained
with hematoxylin and eosin (H&E). The sections were
observed using a fluorescent microscope (OLYMPUS
BX51) and analyzed with the ImageJ software (the Na-
tional Institutes of Health, USA) to calculate the mean
cross-sectional area and the minimal fiber diameter. As
described previously, cross-sectional areas of at least 100
randomly selected myofibers were measured [18]. Myofi-
bers with central nuclei were excluded from analysis
because they could be regenerated myofibers.
Statistical analysis
All data are expressed as mean ± standard error of the
mean (SEM). Statistical analysis was performed using
the SPSS software (version 22). In Study 1, the groups
were compared by two-way analysis of variance
(ANOVA). One-way ANOVA was used in Study 2.
Tukey’s test was performed for post-hoc comparisons. A
P-value of <0.05 or <0.01 was considered to indicate a
statistically significant difference.
Results
Study 1
The food intake, body weight, and plantaris muscle
weight data are summarized in Table 3. The food intake
and initial body weight were similar in all the groups.
The final body weight was slightly lower in the Over-
load group compared to the Sham group (P < 0.05).
In contrast, the weight of each plantaris muscle in
the Overload groups was significantly higher than that
in the Sham groups (P < 0.01). EMIQ supplementa-
tion slightly increased the plantaris muscle weight in
the Overload + EMIQ and Sham + EMIQ groups, al-
though the difference was not statistically significant
(Fig. 1).
To investigate the effect on the plantaris muscle,
the cross-sectional area and minimal diameter of the
myofibers were determined (Fig. 2). The cross-
sectional area was 1559 ± 30 μm2, 1706 ± 51 μm2,
Table 1 Compositions of diets in Study 1
Ingredients(%) CE-2 CE-2 + EMIQ
Carbohydrate 50.500 50.490
Protein 25.000 24. 995
Fat 4.700 4.699
Mineral mixture 6.800 6.799
Fiber 4.000 3.999
Water 9.000 8. 998
EMIQ - 0.003
Total 100 100
Energy (kcal/100 g) 344 344
Table 2 Compositions of diets in Study 2
Ingredients(%) Whey +EMIQ(L) +EMIQ(H)
Cornstarch 39.7486 39.7407 39.6693
Whey protein 20.0000 19.9960 19.9601
α-Cornstarch 13.2000 13.1974 13.1737
Sucrose 10.0000 9.9980 9.9800
Soybean oil 7.0000 6.9986 6.9860
Cellulose 5.0000 4.9990 4.9900
Mineral mixture 3.5000 3.4993 3.4930
Vitamin mixture 1.0000 0.9998 0.9980
L-Cystine 0.3000 0.2999 0.2994
Choline bitartrate 0.2500 0.2500 0.2495
tert-Butylhidroquinone 0.0014 0.0014 0.0014
EMIQ - 0.003 0.03
Total 100 100 100
Energy(Kcal/100 g) 373 373 372
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1820 ± 96 μm2, and 2278 ± 100 μm2 in the Sham,
Sham + EMIQ, Overload, and Overload + EMIQ
groups, respectively. The cross-sectional areas in the
Overload groups were higher than those in the Sham
groups (P < 0.01). The cross-sectional areas in the
EMIQ-treated groups were higher than those in the
untreated groups (P < 0.01). The minimal fiber diam-
eter was 35.9 ± 0.4 μm, 38.6 ± 0.6 μm,
37.7 ± 0.7 μm, and 43.4 ± 0.7 μm in the Sham,
Sham + EMIQ, Overload, and Overload + EMIQ
groups, respectively. The minimal fiber diameters in
the Overload groups were higher than those in the
Sham groups (P < 0.01), and the minimal fiber diam-
eters in the EMIQ-treated groups were higher than
those in the untreated groups (P < 0.01). Two-way
ANOVA detected an interaction between overload op-
eration and EMIQ treatment.
Study 2
To examine the cumulative effect of EMIQ/whey protein
supplementation, we changed the protein source from
milk casein to whey protein and examined overload-
operated mice that received whey only and whey com-
bined with EMIQ at two concentrations. The food in-
take, body weight, and plantaris muscle weight were
similar in all the three groups (Table 4).
To further investigate the effect on the plantaris
muscle, the cross-sectional area and minimal diameter
of myofibers were determined (Fig. 3). The cross-
sectional area in the +EMIQ (H) group was significantly
higher than in the Overload + W and +EMIQ (L) groups
(P < 0.01; Overload + W: 1713 ± 58 μm2, +EMIQ (L):
1795 ± 114 μm2, +EMIQ (H): 2052 ± 73 μm2). More-
over, the minimal fiber diameter in the +EMIQ (H)
group was higher than in the Overload + W and +EMIQ
Table 3 Body and plantaris muscle weight in Study 1
Sham Sham + EMIQ Ovld Ovld + EMIQ P value
Ovld EMIQ Ovld × EMIQ
Food intake (g day−1) 5.1 ± 0.2 5.2 ± 0.2 5.0 ± 0.2 5.0 ± 0.2 0.388 0.711 0.849
Initial body weight (g) 35.9 ± 0.5 35.5 ± 0.7 36.0 ± 0.5 35.0 ± 0.6 0.749 0.222 0.609
Final body weight (g) 39.3a ± 0.6 39.7a ± 0.7 38.1b ± 0.9 37.6b ± 0.6 0.032 0.964 0.547
Left Plantaris (mg) 21.6a ± 1.0 22.7a ± 0.9 43.4b ± 2.3 46.0b ± 3.2 0.000 0.388 0.727
Right Plantaris (mg) 21.8a ± 0.9 23.3a ± 0.8 41.5b ± 3.0 45.3b ± 3.7 0.000 0.298 0.638
Av. Plantaris (mg) 21.7a ± 0.6 23.0a ± 0.8 42.4b ± 2.3 45.6b ± 3.2 0.000 0.290 0.648
Plantaris/B.W. (%) 0.055a ± 0.002 0.058a ± 0.002 0.111b ± 0.005 0.121b ± 0.007 0.000 0.290 0.648
Values are mean ± SEM. Means without a common letter are statistically different (P < 0.05, two-way ANOVA (analysis of variance) followed by Tukey’s test). Sham:
sham-operated mice, Sham + EMIQ: sham-operated mice receiving EMIQ, Ovld: functionally overloaded mice, Ovld + EMIQ: functionally overloaded mice
receiving EMIQ
Fig. 1 Chemical structures
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(L) groups (P < 0.05; Overload + W: 38.3 ± 0.8 μm,
+EMIQ (L): 38.5 ± 1.4 μm, +EMIQ (H): 41.3 ± 0.9 μm).
Discussion
The present study demonstrated that EMIQ supplemen-
tation intensifies muscle fiber hypertrophy in function-
ally overloaded mice. Moreover, EMIQ supplementation
in sham-operated mice and EMIQ/whey protein supple-
mentation also intensified muscle fiber hypertrophy in
this model. Quercetin has been reported to prevent dis-
used muscle atrophy [3, 5]. EMIQ is a quercetin with
improved absorption. In the present study, we showed
that EMIQ can stimulate muscle fiber hypertrophy. Few
studies have found that food ingredients, except pro-
teins, amino acids, and their metabolites, can induce
muscle hypertrophy [19–21].
One possible mechanism of muscle fiber hypertrophy
stimulation by EMIQ is via its antioxidant activity. Func-
tional overlord and eccentric exercise induce inflamma-
tion and oxidative stress in the muscle. According to
many reports, antioxidant supplementation can reduce
the inflammation and oxidative damage, although it is
unclear whether supplementation of antioxidants influ-
ences muscle hypertrophy [22]. Antioxidants are ex-
pected to prevent muscle damage, oxidative stress, and
muscular fatigue, leading to prolonged exercising cap-
acity and muscle hypertrophy. On the contrary, reactive
oxygen species activates important cell signaling path-
ways that mediate skeletal muscle adaptions to exercise,
such as hypertrophy [23]. Vitamin C, a common antioxi-
dant, has been reported to attenuate overload-induced
skeletal muscle hypertrophy [24], though an antioxidant
mixture including rutin promoted muscle protein syn-
thesis by restoring the impaired leucine stimulation [25].
Therefore, specific antioxidants may positively affect
muscle hypertrophy.
Another possible mechanism is related to the effects
of rutin on mitochondria. Recent studies have suggested
that quercetin exerts its beneficial effects independently
of its antioxidant activity. Thus, quercetin modulates
pathways related to mitochondria biogenesis, elevation
of mitochondria membrane potential, oxidative respir-
ation and ATP anabolism, and intra-mitochondrial redox
status [26]. Muscle protein synthesis is a process that
Table 4 Body and plantaris muscle weight in Study 2
Ovld + W Ovld + W + EMIQ(L) Ovld + EMIQ(H)
Total food intake (g) 98.1 ± 2.3 99.0 ± 3.1 98.0 ± 1.6
Body mass (g) 37.2 ± 0.7 36.6 ± 0.8 37.3 ± 0.7
Change of body mass (g) 3.9 ± 0.7 2.9 ± 0.7 3.6 ± 0.4
Left Plantaris (mg) 46.9 ± 1.6 43.1 ± 2.6 43.0 ± 3.1
Right Plantaris (mg) 44.7 ± 4.3 46.3 ± 3.1 43.6 ± 1.7
Av. Plantaris (mg) 45.8 ± 2.9 44.7 ± 2.2 43.3 ± 2.1
Plantaris/B.W. (%) 0.124 ± 0.009 0.123 ± 0.008 0.117 ± 0.007
Values are mean ± SEM. Ovld + W: functionally overloaded mice receiving whey protein, Ovld + W + EMIQ (L): functionally overloaded mice receiving whey
protein and EMIQ at a low concentration, Ovld + W + EMIQ (H): functionally overloaded mice receiving whey protein and EMIQ at a high concentration
Fig. 2 Cross-sectional area (a) and minimal fiber diameter (b) of the plantaris muscle in Study 1. Values are mean ± SEM. Means without a common
letter are statistically different (P < 0.05, two-way ANOVA (analysis of variance) followed by Tukey’s test). Sham: sham-operated mice, Sham + EMIQ:
sham-operated mice receiving EMIQ, Ovld: functionally overloaded mice, Ovld + EMIQ: functionally overloaded mice receiving EMIQ
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requires high utilization of ATP and mitochondria is an
important regulator of intracellular signaling cascades
that modulate skeletal muscle size and function [27].
Dysfunctional mitochondria trigger proteolytic pathways
leading to muscle atrophy during aging. In contrast, ex-
ercise training can induce mitochondrial biogenesis and
dynamics, and increase muscle protein synthesis that fa-
vors myofiber and whole muscle hypertrophy. Overex-
pression of ATP citrate lyase, which improves
mitochondrial function, is sufficient to induce hyper-
trophy in human myotubes [28]. It is therefore possible
that EMIQ induces muscle fiber hypertrophy by affect-
ing mitochondria, although the detailed mechanism
needs to be explored in the future.
A remarkable finding was that EMIQ supplementation
induced muscle fiber hypertrophy even in the sham-
operated group. This result indicates that EMIQ intake
may induce muscle fiber hypertrophy without functional
overload mimicking resistant training. Moreover, EMIQ
supplementation combined with whey protein supple-
mentation also induced muscle fiber hypertrophy in
overload-operated mice. Protein intake after resistance
exercise augments muscle protein synthesis and can lead
to muscle fiber hypertrophy. Whey protein, which con-
tains high amounts of essential branched amino acids
and is absorbed rapidly, is especially effective in this re-
gard [12, 13], resulting in its widespread use by athletes.
Our results suggest that EMIQ supplementation might
have a beneficial effect in athletes; however, it needs to
be validated in a human study.
It has to be noted that the effective concentration of
EMIQ in Study 2 was 10-fold higher than in Study 1,
suggesting that effective EMIQ concentration depends
on the food content. Whey contained in Study 2 is re-
ported to augment muscle hypertrophy dependent on
high content of leucine. Therefore, it is speculated that
the amount of EMIQ to be effective needs to be high.
Study 1 identified an interaction between overload
operation and EMIQ treatment, indicating that the
effective concentration of EMIQ is affected by presence
or absence of functional overload. We speculate that the
effective concentration of EMIQ may depend on specific
details of exercise and/or nutrition. EMIQ can induce
muscle fiber hypertrophy in resistance training and daily
life. Additional studies will be needed to determine the
exact mechanisms and conditions.
Conclusions
EMIQ supplementation intensified the fiber hypertrophy
of the plantaris muscle in mice induced by compensa-
tory overload. Moreover, both EMIQ supplementation
alone and in combination with whey protein intake in-
creased muscle fiber hypertrophy. Given that muscle
fiber hypertrophy is beneficial not only in athletes but
also in the elderly with locomotive syndrome, EMIQ can
be an effective supplement for various sub-populations
in need of muscle fiber hypertrophy and maintenance.
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